Solo-Dex Announces Agreement for Continuous Peripheral Nerve Block Catheters with InfuSystem
WOLF CREEK, MT / ACCESSWIRE / February 22, 2022 / Solo-Dex, Inc. today announced a national distribution agreement for its...
WOLF CREEK, MT / ACCESSWIRE / February 22, 2022 / Solo-Dex, Inc. today announced a national distribution agreement for its...
First development program for which Denali exercised an option under the ongoing and recently expanded collaborationSecarna's LNAplusTM antisense oligonucleotides (ASOs)...
NEW YORK, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the...
Patient data establishes key correlations for therapeutic exposure in tissue and alternative inflammatory pathways, supporting the hypotheses of targeted therapeutic...
--B.C. company brings highest quality fruiting body mushroom formulations to the Canadian nutraceutical marketVANCOUVER, British Columbia., Feb. 22, 2022 (GLOBE...
STI-9167 neutralizing antibody (nAb) maintains high neutralization potency against the recently emerging Omicron sublineage BA.2 as was previously demonstrated for...
JERSEY, Channel Islands, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced...
BOSTON, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights...
KELOWNA, British Columbia., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to...
QuantuMDx announces approval of its Rapid Q-POCTMSARS-CoV-2 assay in the UK under CTDA legislation NEWCASTLE UPON TYNE, UK, 22 February...
Data Published in Cancer Research, a journal of the American Association for Cancer Research Publication highlights potent activity of NXP900,...
In the Phase I clinical trial, participants were administered SPL026 and underwent a 20-minute psychedelic experience Phase I full dataset...
CAMBRIDGE, Mass., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare...
Report Underscores Company’s Expanding Commitment to Being the ”Great Equalizer” in HealthcarePURCHASE, NY, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Teladoc...
Industry veteran with over 20 years of drug development experience to oversee advancement of Acer’s product pipeline Adrian Quartel, MD,...
— Conference call and webcast to be held at 10:00 a.m. ET —BOSTON, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Albireo...
Regional Provider Chooses Automated Coding Analysis for Inpatient and Outpatient Care to Improve Revenue Performance Atlanta, GA, Feb. 22, 2022...
SEATTLE, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (NASDAQ: KDNY), a biopharmaceutical company focused on the discovery, development...
MARLBOROUGH, Mass., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced...
CAMBRIDGE, Mass. and NEW YORK, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology...